Ribosomal protein L26 Antibody - BSA Free
Novus Biologicals, part of Bio-Techne | Catalog # NB100-2130
Conjugate
Catalog #
Key Product Details
Validated by
Independent Antibodies, Biological Validation
Species Reactivity
Validated:
Human, Mouse
Predicted:
Bovine (100%), Rat (100%). Backed by our 100% Guarantee.
Applications
Validated:
Western Blot, Immunoprecipitation, Chromatin Immunoprecipitation (ChIP)
Cited:
Chemotaxis
Label
Unconjugated
Antibody Source
Polyclonal Rabbit IgG
Format
BSA Free
Concentration
1.0 mg/ml
Product Specifications
Immunogen
The immunogen recognized by this antibody maps to a region between residue 1 and 50 of human Ribosomal Protein L26 using the numbering given in entry NP_000978.1 (GeneID 6154).
Clonality
Polyclonal
Host
Rabbit
Isotype
IgG
Description
Novus Biologicals Rabbit Ribosomal protein L26 Antibody - BSA Free (NB100-2130) is a polyclonal antibody validated for use in WB, IP and ChIP. Anti-Ribosomal protein L26 Antibody: Cited in 4 publications. All Novus Biologicals antibodies are covered by our 100% guarantee.
Scientific Data Images for Ribosomal protein L26 Antibody - BSA Free
Western Blot: Ribosomal protein L26 Antibody [NB100-2130] -
Western Blot: Ribosomal protein L26 Antibody [NB100-2130] - Demonstration of the binding of RPL26, RPL4, RPL8, & RPS9 to rs6032664. (A) Allele-imbalanced binding of RPL26, RPL4, RPL8 & RPS9 to the T (risk allele) & A (non-risk allele) of rs6032664 with the statistical analysis based on the relative density. PARP-1 was used as internal loading control & RSRC2 was used as a positive control. (B) Luciferase reporter assays with the risk allele T of rs6032664 demonstrate that RPL26, RPL4, RPL8, & RPS9 are the transcriptional regulators. si: siRNA. (C). ChIP assay showing endogenous binding of RPL26 to rs6032664. (mean ± SD, n = 3 biological replicates, Student t-test with 2 tails). sh: shRNA. NS: not significant. Image collected & cropped by CiteAb from the following publication (https://pubmed.ncbi.nlm.nih.gov/33371207), licensed under a CC-BY license. Not internally tested by Novus Biologicals.Western Blot: Ribosomal protein L26 Antibody [NB100-2130] -
Western Blot: Ribosomal protein L26 Antibody [NB100-2130] - Regulation of disease-associated risk genes STAT4, TRAF1, ICAM1, & CD86 by RPL26 via disease-associated TRN linked by CD40-induced NF-kappa B signal pathway. (A) Western blots showing inactivation of NF-kappa B p65 by dephosphorylation upon CD40L activation in the RPL26 siRNA knockdown FLS. Statistical analysis based on the relative density is shown. (B) real time PCR showing downregulation of four disease-associated risk genes STAT4, TRAF1, ICAM1, & CD86 as the direct targets of NF-kappa B p65, (C) real time PCR showing downregulation of IL6 & IL1 beta as the direct targets of NF-kappa B p65. si: siRNA. Image collected & cropped by CiteAb from the following publication (https://pubmed.ncbi.nlm.nih.gov/33371207), licensed under a CC-BY license. Not internally tested by Novus Biologicals.Applications for Ribosomal protein L26 Antibody - BSA Free
Application
Recommended Usage
Immunoprecipitation
1-4 ug/mg of lysate
Western Blot
1:2500-1:10000
Application Notes
Use in ChIP reported in scientific literature (PMID:33371207).
Formulation, Preparation, and Storage
Purification
Immunogen affinity purified
Formulation
Tris-Citrate/Phosphate (pH 7.0 - 8.0)
Format
BSA Free
Preservative
0.09% Sodium Azide
Concentration
1.0 mg/ml
Shipping
The product is shipped with polar packs. Upon receipt, store it immediately at the temperature recommended below.
Stability & Storage
Store at 4C. Do not freeze.
Background: Ribosomal protein L26
Alternate Names
ribosomal protein L26,60S ribosomal protein L26
Gene Symbol
RPL26
UniProt
Additional Ribosomal protein L26 Products
Product Documents for Ribosomal protein L26 Antibody - BSA Free
Product Specific Notices for Ribosomal protein L26 Antibody - BSA Free
This product is for research use only and is not approved for use in humans or in clinical diagnosis. Primary Antibodies are guaranteed for 1 year from date of receipt.
Loading...
Loading...
Loading...
Loading...